KZA Removal from Official List |
15/11/23 | | 87.34KB | Share |
|
KZA Change in substantial holding |
14/11/23 | | 1.51MB | Share |
|
KZA Suspension from Official List |
13/11/23 | PRICE SENSITIVE | 86.69KB | Share |
|
KZA Change in substantial holding |
08/11/23 | | 1.59MB | Share |
|
KZA Notice of Annual General Meeting/Proxy Form |
03/11/23 | | 1.07MB | Share |
|
KZA Preliminary update from ongoing Phase 2 Study of Paxalisib |
02/11/23 | | 150.76KB | Share |
|
KZA Proposed issue of securities - KZA |
31/10/23 | | 24.89KB | Share |
|
KZA Kazia announces short term unsecured Promissory Note |
31/10/23 | PRICE SENSITIVE | 169.34KB | Share |
|
KZA Quarterly Activities/Appendix 4C Cash Flow Report |
31/10/23 | PRICE SENSITIVE | 253.76KB | Share |
|
KZA Kazia SEC Form 20-F |
27/10/23 | | 630.23KB | Share |
|
KZA Kazia announces Clinical Data at ESMO 2023 from EVT801 Study |
24/10/23 | | 167.72KB | Share |
|
KZA Change in substantial holding |
23/10/23 | | 1.51MB | Share |
|
KZA Change of AGM date |
16/10/23 | | 127.98KB | Share |
|
KZA Shareholder communication on the ASX de-listing process |
13/10/23 | PRICE SENSITIVE | 667.16KB | Share |
|
KZA Reinstatement to Official Quotation |
11/10/23 | PRICE SENSITIVE | 408.79KB | Share |
|
KZA Kazia announces intention to voluntarily de-list from ASX |
11/10/23 | PRICE SENSITIVE | 226.44KB | Share |
|
KZA Voluntary Suspension |
10/10/23 | PRICE SENSITIVE | 299.26KB | Share |
|
KZA Trading Halt |
06/10/23 | PRICE SENSITIVE | 1.03MB | Share |
|
KZA Presentations at upcoming scientific meetings |
05/10/23 | | 128.19KB | Share |
|
KZA Acceptance of late-breaking abstract of PNOC022 data |
29/09/23 | PRICE SENSITIVE | 129.86KB | Share |
|
KZA Change in substantial holding |
11/09/23 | | 1.52MB | Share |
|
KZA 2023 Corporate Governance Statement |
31/08/23 | | 219.65KB | Share |
|
KZA Appendix 4G |
31/08/23 | | 275.48KB | Share |
|
KZA Appendix 4E and 2023 Annual Report |
31/08/23 | PRICE SENSITIVE | 6.51MB | Share |
|
KZA Final Director's Interest Notice - Iain Ross |
11/08/23 | | 231.26KB | Share |
|
KZA Cleansing Notice - updated |
11/08/23 | | 131.48KB | Share |
|
KZA Cleansing Notice |
11/08/23 | | 130.98KB | Share |
|
KZA Application for quotation of securities - KZA |
11/08/23 | | 26.63KB | Share |
|
KZA Kazia announces change to Board of Directors |
11/08/23 | | 125.76KB | Share |
|
KZA Appointment of Dr John Friend as Managing Director |
01/08/23 | | 272.73KB | Share |
|
KZA Quarterly Activities/Appendix 4C Cash Flow Report |
31/07/23 | PRICE SENSITIVE | 318.42KB | Share |
|
KZA Notification regarding unquoted securities - KZA |
19/07/23 | | 26.04KB | Share |
|
KZA Change in substantial holding |
17/07/23 | | 210.33KB | Share |
|
KZA Cleansing Notice |
14/07/23 | | 154.33KB | Share |
|
KZA Appendix 2A |
14/07/23 | | 177.14KB | Share |
|
KZA Proposed issue of securities - KZA |
14/07/23 | | 25.07KB | Share |
|
KZA Notification of cessation of securities - KZA |
13/07/23 | | 22.53KB | Share |
|
KZA Change in substantial holding |
11/07/23 | | 1.5MB | Share |
|
KZA Paxalisib receives Fast Track Designation from US FDA |
07/07/23 | | 183.55KB | Share |
|
KZA Kazia Corporate Update and Corporate Presentation |
26/06/23 | | 2.61MB | Share |
|
KZA Launch of LUMOS2 Study |
08/06/23 | | 163.17KB | Share |
|
KZA Constitution |
07/06/23 | | 493.48KB | Share |
|
KZA Appointment of Non-executive Director |
05/06/23 | | 278.65KB | Share |
|
KZA Kazia CEO participates in White House Cancer Moonshot Forum |
26/05/23 | | 138.12KB | Share |
|
KZA Cancel - Notification of cessation of securities - KZA |
25/05/23 | | 24.21KB | Share |
|
KZA Quarterly Activities/Appendix 4C Cash Flow Report - updated |
09/05/23 | | 410KB | Share |
|
KZA Notification regarding unquoted securities - KZA |
08/05/23 | | 29.85KB | Share |
|
KZA Notification of cessation of securities - KZA |
05/05/23 | | 24.66KB | Share |
|
KZA Final Director's Interest Notice - Dr J Garner |
02/05/23 | | 231.28KB | Share |
|
KZA Executive Leadership changes - Dr John Friend appointed CEO |
01/05/23 | PRICE SENSITIVE | 120.26KB | Share |
|
KZA Quarterly Activities/Appendix 4C Cash Flow Report |
28/04/23 | PRICE SENSITIVE | 332.77KB | Share |
|
KZA Kazia regains compliance with Nasdaq minimum bid requirement |
14/04/23 | | 106.63KB | Share |
|
KZA Notification of cessation of securities - KZA |
12/04/23 | | 24.69KB | Share |
|
KZA Change in substantial holding |
06/04/23 | | 1.5MB | Share |
|
KZA Kazia presents new data at AACR Annual Meeting |
04/04/23 | | 173.16KB | Share |
|
KZA Change of Director's Interest Notice |
21/03/23 | | 312.82KB | Share |
|
KZA Change of Director's Interest Notice |
17/03/23 | | 294.82KB | Share |
|
KZA Notification of cessation of securities - KZA |
08/03/23 | | 24.67KB | Share |
|
KZA Clinical Collaboration for Phase II clinical study |
07/03/23 | | 160.64KB | Share |
|
KZA Change in substantial holding |
07/03/23 | | 1.55MB | Share |
|
KZA Change in substantial holding |
06/03/23 | | 148.69KB | Share |
|
KZA Change of Director's Interest Notices |
06/03/23 | | 444.7KB | Share |
|
KZA Notification regarding unquoted securities - KZA |
06/03/23 | | 29.01KB | Share |
|
KZA Cleansing Notice |
03/03/23 | | 131.87KB | Share |
|
KZA Application for quotation of securities - KZA |
03/03/23 | | 25.5KB | Share |
|
KZA Change in substantial holding |
02/03/23 | | 1.56MB | Share |
|
KZA Resignation and appointment of Company Secretary |
28/02/23 | | 151.11KB | Share |
|
KZA Half Yearly Report and Accounts |
28/02/23 | PRICE SENSITIVE | 619.33KB | Share |
|
KZA Kazia result of Share Purchase Plan |
28/02/23 | PRICE SENSITIVE | 167.59KB | Share |
|
KZA Cleansing notice |
28/02/23 | | 177.02KB | Share |
|
KZA Application for quotation of securities - KZA |
28/02/23 | | 25.69KB | Share |
|
KZA Results of EGM |
24/02/23 | | 196.2KB | Share |
|
KZA Details of Auditor Appointment/Resignation |
24/02/23 | | 157.39KB | Share |
|
KZA Quarterly Activities/Appendix 4C Cash Flow Report |
15/02/23 | PRICE SENSITIVE | 581.96KB | Share |
|
KZA Quarterly Activities/Appendix 4C Cash Flow Report |
31/01/23 | PRICE SENSITIVE | 448.31KB | Share |
|
KZA Substantial shareholder notice |
24/01/23 | | 171.53KB | Share |
|
KZA Kazia Share Purchase Plan |
19/01/23 | | 341.72KB | Share |
|
KZA Notice of Extraordinary General Meeting/Proxy Form |
19/01/23 | | 410.52KB | Share |
|
KZA Change in substantial holding |
18/01/23 | | 225.02KB | Share |
|
KZA Change in substantial holding |
18/01/23 | | 1.52MB | Share |
|
KZA Cleansing notice |
17/01/23 | | 176.79KB | Share |
|
KZA Cleansing notice |
17/01/23 | | 76.48KB | Share |
|
KZA Application for quotation of securities - KZA |
17/01/23 | | 25.9KB | Share |
|
KZA Application for quotation of securities - KZA |
17/01/23 | | 25.79KB | Share |
|
KZA Proposed issue of securities - KZA |
17/01/23 | | 27.62KB | Share |
|
KZA Proposed issue of securities - KZA |
16/01/23 | | 25.45KB | Share |
|
KZA Kazia raises $4.5m and launches share purchase plan |
16/01/23 | PRICE SENSITIVE | 240.25KB | Share |
|
KZA Trading Halt |
12/01/23 | PRICE SENSITIVE | 212.37KB | Share |
|
KZA Kazia pre-clinical collaboration with QIMR |
15/12/22 | | 177.47KB | Share |
|
KZA Kazia receives Nasdaq minimum bid notice |
13/12/22 | | 184.61KB | Share |
|
KZA EVT801 preclinical data published |
01/12/22 | PRICE SENSITIVE | 229.77KB | Share |
|
KZA Kazia AGM results |
16/11/22 | | 479.98KB | Share |
|
KZA AGM materials |
16/11/22 | | 748.3KB | Share |
|
KZA Change in substantial holding |
14/11/22 | | 1.53MB | Share |
|
KZA Kazia presents to Bell Potter Healthcare Conference |
09/11/22 | | 1.25MB | Share |
|
KZA Kazia to present to SNO |
09/11/22 | | 156.31KB | Share |
|
KZA Change in substantial holding |
07/11/22 | | 1.6MB | Share |
|
KZA Cleansing notice |
04/11/22 | | 76.44KB | Share |
|
KZA Application for quotation of securities - KZA |
04/11/22 | | 25.89KB | Share |
|
KZA Withdrawal of resolution |
03/11/22 | | 150.9KB | Share |